trending Market Intelligence /marketintelligence/en/news-insights/trending/cUM9IcgNpJS2pQ8SWXtfYQ2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Editas Medicine CFO to step down

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


Editas Medicine CFO to step down

Editas Medicine Inc. said Andrew Hack would resign as the company's CFO to pursue other business interests, effective March 1, 2019.

The company said it is looking for a replacement.

Cambridge, Mass.-based Editas Medicine operates as a genome editing company.